Study IDs 'Standard' Chemo for BRCA, PALB2 Pancreatic Cancer

]]>(MedPage Today) -- SAN FRANCISCO--Gemcitabine (Gemzar) plus cisplatin should be considered a standard for metastatic pancreatic cancer patients with germline BRCA or PALB2 mutations, experts here said.In a randomized phase II trial of 50...